EUVIMEDEUVIMED entdecken
Crossref

Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors

Emily K. Bergsland

Journal of the National Comprehensive Cancer Network · 2025-05 · 23 (Supplement)

DOI: 10.6004/jnccn.2025.5012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025-05. Verfasst von Emily K. Bergsland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine neoplasms (NENs) comprise a diverse group of tumors that can arise throughout the body, making classification and treatment particularly complex. The NCCN Guidelines for Neuroendocrine and Adrenal Tumors have expanded to include treatment options based on the location, stage, and grade of the tumor, However, these treatment approaches rely on accurate pathologic classification of the tumor and correlation with imaging and clinical features. With a growing list of available systemic treatment options for advanced tumors and a disease continuum often measured in years, if not decades in some patients, treatment sequencing, quality of life, and potential long-term side effects remain important considerations.

Zitieren

APA

Bergsland, E. K. (2025). Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors. Journal of the National Comprehensive Cancer Network, 23(Supplement). https://doi.org/10.6004/jnccn.2025.5012

Vancouver

Bergsland EK. Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors. Journal of the National Comprehensive Cancer Network. 2025;23(Supplement). doi:10.6004/jnccn.2025.5012

BibTeX
@article{Bergsland2025,
  author = {Bergsland, Emily K.},
  title = {Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2025},
  volume = {23},
  number = {Supplement},
  doi = {10.6004/jnccn.2025.5012}
}
Kostenlos starten →